[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100614497":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":13,"centralContacts":17,"locations":27,"responsibleParty":42,"collaborators":7,"id":44,"slug":45,"hasResults":46,"nctId":47,"briefTitle":48,"officialTitle":48,"acronym":7,"eligibilityCriteria":49,"healthyVolunteers":46,"sex":50,"minAge":51,"maxAge":52,"enrollmentInfo":53,"targetDuration":7,"studyType":56,"phases":7,"briefSummary":57,"conditions":58,"keywords":60,"overallStatus":30,"whyStopped":7,"lastUpdateSubmitDate":65,"lastUpdatePostDateStruct":66,"startDateStruct":69,"completionDateStruct":71,"leadSponsor":73,"locationsCount":74},{"fullName":5,"class":6},"I.M. Sechenov First Moscow State Medical University","OTHER",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":7},"DRUG","Standart medical treatment","No intervention, patients will recieve standard medical treatment",[14],{"name":15,"affiliation":5,"role":16},"Natalia A. Geppe, MD, Doctor of M.Sc., Professor","PRINCIPAL_INVESTIGATOR",[18,23],{"name":19,"role":20,"phone":21,"phoneExt":7,"email":22},"Natalia A. Geppe, MD, Doctor of M.Sc, Professor","CONTACT","+7-499-248-44-22","geppe@mail.ru",{"name":24,"role":20,"phone":25,"phoneExt":7,"email":26},"Irina V. Ozerskaia, MD, PhD","+7-926-387-25-12","ozerskaya_i_v@staff.sechenov.ru",[28],{"facility":29,"status":30,"city":31,"state":7,"zip":7,"country":32,"countryCode":33,"cosmosGeoPoint":34,"geoPoint":39,"contacts":40},"I.M. Sechenov First Moscow State Medical University (Sechenov University)","RECRUITING","Moscow","Russia","RU",{"type":35,"coordinates":36},"Point",[37,38],37.61781,55.75204,{"lat":38,"lon":37},[41],{"name":24,"role":20,"phone":25,"phoneExt":7,"email":26},{"type":43,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100614497","metabolomics-in-the-diagnosis-and-treatment-of-asthma-in-children-100614497",false,"NCT07280364","Metabolomics in the Diagnosis and Treatment of Asthma in Children","Inclusion Criteria:\n\n* Age from 12 to 17 years old\n* Confirmed diagnosis of asthma\n* Informed voluntary consent to participate in the study\n\nExclusion Criteria:\n\n* age under 12 years\n* no established diagnosis of asthma\n* concomitant severe somatic, metabolic, and endocrine diseases\n* patient's withdrawal of informed consent","ALL","12 Years","17 Years",{"count":54,"type":55},100,"ESTIMATED","OBSERVATIONAL","The goal of this observational study is to learn about the metabolomic profile of blood and urine in children 12-17 years with asthma. The main question it aims to answer is:\n\n• Are there metabolites in the blood and urine that are specific for asthma exacerbation? Participants already receive standard therapy as part of their regular medical care for asthma.",[59],"Asthma",[61,62,63,64],"bronchial asthma","children","metabolomics","metabolites","2026-01-27",{"date":67,"type":68},"2026-01-28","ACTUAL",{"date":70,"type":68},"2024-03-13",{"date":72,"type":55},"2026-08",{"name":5,"class":6},1]